A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression

@article{Dougherty2015ARS,
  title={A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression},
  author={Darin D. Dougherty and Ali R. Rezai and Linda L. Carpenter and Robert H. Howland and Mahendra T. Bhati and John P O'reardon and Emad N. Eskandar and Gordon Baltuch and Andr{\'e} Dallago Machado and Douglas Kondziolka and Cristina Cusin and Karleyton C. Evans and Lawrence H Price and Karen Jacobs and Mayur Pandya and Timothey C. Denko and Audrey R. Tyrka and Tim Brelje and Thilo Deckersbach and Cynthia S. Kubu and Donald Malone},
  journal={Biological Psychiatry},
  year={2015},
  volume={78},
  pages={240-248}
}
Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression
TLDR
The data suggest that VC/VS DBS in patients with TRD does not significantly affect neuropsychological function, and age at surgery, regardless of stimulation status, may be related to cognitive outcome at the individual patient level.
Deep brain stimulation for treatment-resistant depression: optimizing interventions while preserving valid trial design.
TLDR
Two disparate results suggest that a better understanding of the circuitry that DBS is targeting is needed in order to obtain more consistent outcomes in patients with treatment resistant depression.
Long-term deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression
Objective Deep brain stimulation (DBS) reduces depressive symptoms in approximately 40%–60% of patients with treatment-resistant depression (TRD), but data on long-term efficacy and safety are
A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression
TLDR
This longitudinal evaluation of MFB DBS demonstrated rapid antidepressant effects, as initially reported by Schlaepfer et al. (2013), and supports the use of DBS for TRD.
Impact of deep brain stimulation of the ventral anterior limb of the internal capsule on cognition in depression
Background Preliminary studies report no negative and a possible positive impact of deep brain stimulation (DBS) on cognition of patients with treatment-resistant depression (TRD). However, these
Deep Brain Stimulation for Depression: Keeping an Eye on a Moving Target.
TLDR
The implicit instability of the DBS response reported in this study provides new evidence that experimental studies using invasived treatments might best be structured so that they are not prematurely terminated at an arbitrary timepoint.
Role of Deep Brain Stimulation in Treatment Resistant Depression: A Review Article
TLDR
DBS in the neuroanatomical structures of the Subcallosal Cingulate Gyrus, Anterior Limb of Internal Capsule, Ventral Capsule/Ventral Septum, Medial Forebrain Bundle, and Nucleus Accumbans yielded more reliable antidepressant success rates in cases with TRD, but more well-designed randomized double-blind, controlled trials are necessary to entirely evaluate the efficiency, safety and compatibility of these DBS targets.
Deep brain stimulation of the “medial forebrain bundle”: sustained efficacy of antidepressant effect over years
TLDR
Evaluation of modulated fiber tracts reveals significant common prefrontal/orbitofrontal connectivity to the target region in all responders, showing sustained antidepressant effect up to 5 years of DBS to superolateral branch of the medial forebrain bundle.
...
...

References

SHOWING 1-10 OF 19 REFERENCES
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression.
TLDR
Findings from this study corroborate the results of previous reports showing that outcome of SCG DBS may be replicated across centers and are associated with amelioration in disease severity in patients who responded to surgery.
Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience
TLDR
Combined long-term results of DBS studies show that the procedure can be successfully implemented by dedicated interdisciplinary teams, and support its therapeutic promise, and suggest that neural networks relevant to therapeutic improvement might be modulated more effectively at a more posterior target.
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression.
TLDR
The findings of this study support the long-term safety and antidepressant efficacy of subcallosal cingulate DBS forTRD and suggest equivalent safety and efficacy for TRD in patients with BP.
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years.
TLDR
Deep brain stimulation remains a safe and effective treatment for treatment-resistant depression and functional impairment in the areas of physical health and social functioning progressively improved up to the last follow-up visit.
Epidural Cortical Stimulation of the Left Dorsolateral Prefrontal Cortex for Refractory Major Depressive Disorder
TLDR
Epidural cortical stimulation of the left dorsolateral prefrontal cortex appears to be a safe and potentially efficacious neuromodulation approach for treatment-refractory major depressive disorder.
Long term outcome of thermal anterior capsulotomy for chronic, treatment refractory depression
TLDR
ACAPS may represent an effective intervention for some patients with chronic, disabling, treatment refractory major depression that has failed to respond to other therapeutic approaches, and the adverse effect burden within this population was modest.
Magnetic Resonance Imaging-guided Stereotactic Limbic Leukotomy for Treatment of Intractable Psychiatric Disease
TLDR
For this cohort of 21 patients with chronic severe MDD or OCD, limbic leukotomy was associated with substantial benefit for 36 to 50%.
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
TLDR
When more treatment steps are required, lower acute remission rates (especially in the third and fourth treatment steps) and higher relapse rates during the follow-up phase are to be expected.
...
...